Nanoparticles laden in situ gel of levofloxacin for enhanced ocular retention

Drug Delivery

Volumn 20, Issue 7, 2013, Pages 306-309

  Gupta, Himanshu ^a,b   Aqil, M ^a   Khar, R K ^a   Ali, Asgar ^a   Bhatnagar, Aseem ^b   Mittal, Gaurav ^b  

^a HAMDARD UNIVERSITY   (India)

^b INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

Gamma scintigraphy; in situ gel; Levofloxacin; Nanoparticle; Nanoparticle laden in situ gel; Ocular; PLGA

Indexed keywords

CHITOSAN; LEVOFLOXACIN; NANOPARTICLE; POLYGLACTIN; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORNEA; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG FORMULATION; DRUG RETENTION; DRUG SCREENING; DRUG SYNTHESIS; EXPERIMENTAL RABBIT; FEMALE; GAMMA CAMERA; GAMMA SCINTIGRAPHY; GEL; ISOTOPE LABELING; MALE; NANOENCAPSULATION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SUSPENSION;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL AVAILABILITY; CHITOSAN; CORNEA; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; GELS; LACTIC ACID; LEVOFLOXACIN; MALE; NANOPARTICLES; POLYGLYCOLIC ACID; RABBITS; RADIONUCLIDE IMAGING; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 84884553126     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2013.838712     Document Type: Article

References (5)

1. Gupta H, Aqil M, Khar RK, et al. (2009). Development and characterization of Tc-99m timolol maleate for evaluating efficacy of in situ ocular drug delivery system. AAPS Pharm Sci 10:540-6.
2. Gupta H, Aqil M, Khar RK, et al. (2010). Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery. J Drug Target 19: 409-17.
3. Maurice DM. (1987). Kinetics of topical applied drugs. In: Saettone MS, Bucci P, Speiser P, eds. Ophthalmic drug delivery, biopharmaceutical, technological and clinical aspects. Fidia Research Series. Padova, Italy: Liviana Press, Vol. 11, 19-26.
4. Nanjawade BK, Manvi FV, Manjappa AS. (2007). In situ-forming hydrogels for sustained ophthalmic drug delivery. J Control Rel 122: 119-34.
5. Schoenwald RD. (1990). Ocular drug delivery: pharmacokinetic considerations. Clin Pharmacokinet 18:255-69.